欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/2418/003
药品名称Mirtazapine Grindeks
活性成分
    • Mirtazapine 45.0 mg
剂型Orodispersible tablet
上市许可持有人Grindeks AS Latvia
参考成员国 - 产品名称Sweden (SE)
Mirtazapine Grindeks
互认成员国 - 产品名称
    • Germany (DE)
      Mirtazapine Grindeks 45 mg Schmelztabletten
    • Poland (PL)
      Mirtazapine Grindeks
    • Denmark (DK)
      Mirtazapin ”Grindeks”
    • Latvia (LV)
    • Belgium (BE)
      Mirtazapine Grindeks 45 mg orodispergeerbare tabletten
    • Lithuania (LT)
    • Ireland (IE)
    • Estonia (EE)
    • Austria (AT)
    • Hungary (HU)
      Mirtazapine Grindeks 45 mg szájban diszpergálódó tabletta
    • France (FR)
    • Bulgaria (BG)
      Mirtazapine Grindeks
    • Spain (ES)
    • Czechia (CZ)
      Mirtazapine Grindeks
    • Portugal (PT)
    • Slovenia (SI)
    • Italy (IT)
    • Croatia (HR)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
许可日期2025/07/09
最近更新日期2025/09/12
药物ATC编码
    • N06AX11 mirtazapine
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase